Goldman Sachs Group Inc Dice Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 May 14, 2024	BUY	$25.86 - $46.71 $14.2 Million - $25.7 Million	549,422 Added 348.58%	707,039 $32.8 Million
Q2 2023 Aug 14, 2023	BUY	$25.86 - $46.71 $14.2 Million - $25.7 Million	549,422 Added 348.58%	707,039 $32.8 Million
Q1 2023 May 14, 2024	SELL	$26.05 - $32.31 $348,809 - $432,630	-13,390 Reduced 7.83%	157,617 $4.52 Million
Q1 2023 May 11, 2023	SELL	$26.05 - $32.31 $348,809 - $432,630	-13,390 Reduced 7.83%	157,617 $4.52 Million
Q4 2022 May 14, 2024	BUY	$19.77 - $42.23 $2.54 Million - $5.43 Million	128,646 Added 303.69%	171,007 $5.34 Million
Q4 2022 Feb 13, 2023	BUY	$19.77 - $42.23 $2.54 Million - $5.43 Million	128,646 Added 303.69%	171,007 $5.34 Million
Q3 2022 May 14, 2024	BUY	$14.97 - $22.65 $422,318 - $638,979	28,211 Added 199.37%	42,361 $859,000
Q3 2022 Nov 10, 2022	BUY	$14.97 - $22.65 $422,318 - $638,979	28,211 Added 199.37%	42,361 $859,000
Q2 2022 May 14, 2024	BUY	$13.19 - $22.1 $186,638 - $312,715	14,150 New	14,150 $220,000
Q2 2022 Aug 15, 2022	BUY	$13.19 - $22.1 $14,706 - $24,641	1,115 Added 8.55%	14,150 $220,000
Q1 2022 May 16, 2022	BUY	$14.54 - $25.02 $189,528 - $326,135	13,035 New	13,035 $249,000
Q4 2021 Feb 14, 2022	SELL	$22.41 - $37.54 $873,990 - $1.46 Million	-39,000 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$31.92 - $37.0 $1.24 Million - $1.44 Million	39,000 New	39,000 $1.28 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.